{"database": "openregs", "table": "documents", "rows": [["FDA-2000-N-0108-0073", "FDA", "FDA-2000-N-0108", "Reference 1.  \"Detailed Guidance on the Collection, Verification and Presentation of Adverse Reaction Reports Arising From Clinical Trials on Medicinal Products for Human Use\" [Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans, Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-09-29T04:00:00Z", 2010, 9, null, null, "2010-09-29T15:03:54Z", null, 0, 0, "0900006480b62574"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2000-N-0108-0073"], "units": {}, "query_ms": 0.5468940362334251, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}